CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project develops non-invasive imaging techniques to assess early treatment responses in cancer, particularly Hodgkin lymphoma. By utilizing advanced methods to detect metabolic changes in tumors, the goal is to improve patient outcomes by tailoring therapies based on individual responses.
Assessing treatment response in cancer is the most important single prognostic factor for a patient.
Therefore, it is crucial to detect response as early as possible during treatment.
Additionally, similar tumour types frequently have markedly different responses to the same therapy.
Hodgkin lymphoma, for example, is one of the tumour types where a small group of patients fail to respond or respond poorly to treatment.
The early evaluation of a specific treatment allows targeting effective thera…
CANCER RESEARCH UK LBG
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
